Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FD6H4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,770
Award facts
- Contract value 100% obligated
- $38,770.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,770.14 to AmerisourceBergen Drug Corp for the supply of Wegovy 1 mg/0.5 mL pen injections (0.5 mL), with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, issued on July 24, 2025, was awarded competitively without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The SPE2DX global pharmaceutical support vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities. The delivery order for Wegovy reflects the company's role in supplying specialty pharmaceutical products, in this case a GLP-1 receptor agonist commonly used for weight management, to support Defense Health Agency requirements and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FD6H4?
SPE2DB25FD6H4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FD6H4 worth?
The government has obligated $38,770 on SPE2DB25FD6H4.
Is contract SPE2DB25FD6H4 an order under another contract?
Yes. SPE2DB25FD6H4 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD6H4 competed?
The extent of competition for SPE2DB25FD6H4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award